07:00 , Apr 9, 2012 |  BC Week In Review  |  Clinical News

BD Max Cdiff Assay regulatory update

Becton Dickinson's BD Diagnostics segment received CE Mark approval for its BD Max Cdiff Assay for use on the company's BD MAX system to detect Clostridium difficile infection. BD Diagnostics said the assay detects the...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Clinical News

BD Max GBS Assay regulatory update

FDA granted clearance to Becton Dickinson's BD MAX GBS Assay to detect group B streptococcus (GBS) colonization status for use on the company's second-generation BD MAX System. The company also said the assay received CLIA...
07:00 , Jun 14, 2010 |  BC Week In Review  |  Clinical News

BD Max GBS Assay regulatory update

FDA granted 510(k) clearance to Becton Dickinson's BD MAX GBS Assay to detect group B streptococcus (GBS) colonization status. The PCR assay is designed for use on the company's BD MAX System. Becton Dickinson and...